King V - Search Results

1

Microarray analyses demonstrate the involvement of type I interferons in psoriasiform pathology development in D6-deficient mice.

Baldwin HM, Pallas K, King V, Jamieson T, McKimmie CS, Nibbs RJ, Carballido JM, Jaritz M, Rot A, Graham GJ. Baldwin HM, et al. Among authors: king v. J Biol Chem. 2013 Dec 20;288(51):36473-83. doi: 10.1074/jbc.M113.491563. Epub 2013 Nov 5. J Biol Chem. 2013. PMID: 24194523 Free PMC article.

2

Elevated expression of the chemokine-scavenging receptor D6 is associated with impaired lesion development in psoriasis.

Singh MD, King V, Baldwin H, Burden D, Thorrat A, Holmes S, McInnes IB, Nicoll R, Shams K, Pallas K, Jamieson T, Lee KM, Carballido JM, Rot A, Graham GJ. Singh MD, et al. Among authors: king v. Am J Pathol. 2012 Oct;181(4):1158-64. doi: 10.1016/j.ajpath.2012.06.042. Epub 2012 Aug 4. Am J Pathol. 2012. PMID: 22867710 Free PMC article.

3

The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors.

Nibbs RJ, Gilchrist DS, King V, Ferra A, Forrow S, Hunter KD, Graham GJ. Nibbs RJ, et al. Among authors: king v. J Clin Invest. 2007 Jul;117(7):1884-92. doi: 10.1172/JCI30068. J Clin Invest. 2007. PMID: 17607362 Free PMC article.

4

Elevated ACKR2 expression is a common feature of inflammatory arthropathies.

Baldwin HM, Singh MD, Codullo V, King V, Wilson H, McInnes I, Graham GJ. Baldwin HM, et al. Among authors: king v. Rheumatology (Oxford). 2017 Sep 1;56(9):1607-1617. doi: 10.1093/rheumatology/kex176. Rheumatology (Oxford). 2017. PMID: 28486662 Free PMC article.

5

IL-5 links adaptive and natural immunity in reducing atherosclerotic disease.

Daugherty A, Rateri DL, King VL. Daugherty A, et al. J Clin Invest. 2004 Aug;114(3):317-9. doi: 10.1172/JCI22561. J Clin Invest. 2004. PMID: 15286796 Free PMC article. Review.

6

Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice.

King VL, Cassis LA, Daugherty A. King VL, et al. Am J Pathol. 2007 Dec;171(6):2040-7. doi: 10.2353/ajpath.2007.060857. Epub 2007 Nov 30. Am J Pathol. 2007. PMID: 18055554 Free PMC article.

7

Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner.

Wilson PG, Thompson JC, Webb NR, de Beer FC, King VL, Tannock LR. Wilson PG, et al. Am J Pathol. 2008 Dec;173(6):1902-10. doi: 10.2353/ajpath.2008.080201. Epub 2008 Oct 30. Am J Pathol. 2008. PMID: 18974302 Free PMC article.

8

Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice.

King VL, Szilvassy SJ, Daugherty A. King VL, et al. Arterioscler Thromb Vasc Biol. 2002 Mar 1;22(3):456-61. doi: 10.1161/hq0302.104905. Arterioscler Thromb Vasc Biol. 2002. PMID: 11884290

9

Interleukin-4 deficiency promotes gallstone formation.

King VL, Szilvassy SJ, Daugherty A. King VL, et al. J Lipid Res. 2002 May;43(5):768-71. J Lipid Res. 2002. PMID: 11971948 Free article.

10

Thematic review series: The immune system and atherogenesis. Cytokine regulation of macrophage functions in atherogenesis.

Daugherty A, Webb NR, Rateri DL, King VL. Daugherty A, et al. J Lipid Res. 2005 Sep;46(9):1812-22. doi: 10.1194/jlr.R500009-JLR200. Epub 2005 Jul 1. J Lipid Res. 2005. PMID: 15995168 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

570 results

Search Page

Filters